You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NTRK3

Showing 51 - 74 of 74
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Invasive Lobular Breast Carcinoma, ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Belgium, France (Entrectinib,

Recruiting
  • Invasive Lobular Breast Carcinoma
  • +2 more
  • Brussels, Belgium
  • +9 more
May 4, 2022

NSCLC Trial in Guangzhou (Avitinib Maleate, Afatinib, Crizotinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Avitinib Maleate
  • +13 more
  • Guangzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Dec 3, 2022

Metastatic Lung Cancer Trial in France (InvisionFirst® molecular panel)

Active, not recruiting
  • Metastatic Lung Cancer
  • InvisionFirst® molecular panel
  • Bayeux, France
  • +15 more
Aug 22, 2022

Non Small Cell Lung Cancer Metastatic, Newly Diagnosed NSCLC, Non-Squamous Non-Small Cell Tumor of Lung Trial in United States

Not yet recruiting
  • Non Small Cell Lung Cancer Metastatic
  • +2 more
  • iNUDGE
  • Cherry Hill, New Jersey
  • +5 more
May 9, 2023

NSCLC Trial in Worldwide (Osimertinib, Savolitinib, Gefitinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Duarte, California
  • +52 more
Jan 19, 2023

CNS Tumor, Infantile Fibrosarcoma, Recurrent Acute Leukemia Trial in Canada, United States (Larotrectinib Sulfate)

Active, not recruiting
  • Central Nervous System Neoplasm
  • +4 more
  • Larotrectinib Sulfate
  • Birmingham, Alabama
  • +81 more
Jan 24, 2023

Solid Tumors Trial in Worldwide (Entrectinib, Alectinib, Atezolizumab)

Recruiting
  • Solid Tumors
  • Daphne, Alabama
  • +156 more
Jan 13, 2023

Solid Tumors Harboring NTRK Fusion Trial in Mannheim (Selitrectinib (BAY2731954))

Completed
  • Solid Tumors Harboring NTRK Fusion
  • Selitrectinib (BAY2731954)
  • Mannheim, Baden-Württemberg, Germany
    CRS Clinical-Research-Services Mannheim GmbH
Dec 28, 2020

Breast Cancer, Gastrointestinal Cancer, Non Small Cell Lung Cancer Trial in Italy (Erlotinib, Trastuzumab, Trastuzumab

Recruiting
  • Breast Cancer
  • +3 more
  • Ancona, Italy
  • +40 more
Jan 25, 2023

Cancer, Advanced Solid Tumor Trial in Kettering (lorlatinib, encorafenib + binimetinib, talazoparib)

Recruiting
  • Cancer
  • Advanced Solid Tumor
  • Kettering, Ohio
    Kettering Health Network
Oct 14, 2022

Solid Tumors Harboring NTRK Fusion Trial in Glendale, Baltimore (Selitrectinib (BAY2731954) Adult tablet, Selitrectinib

Completed
  • Solid Tumors Harboring NTRK Fusion
  • Selitrectinib (BAY2731954) Adult tablet
  • +3 more
  • Glendale, California
  • +1 more
Aug 24, 2021

Advanced Cancer Trial in Korea, Republic of, United States (MGCD516)

Unknown status
  • Advanced Cancer
  • Birmingham, Alabama
  • +42 more
Jan 28, 2020

Solid Tumor Trial in United Kingdom, United States (ONO-7579)

Terminated
  • Solid Tumor
  • Lake Success, New York
  • +4 more
Sep 11, 2019

Determine the Incidence of NTRK Fusions. NTRK Study

Unknown status
  • Metastatic Solid Tumors
  • Retrospective cohort
  • Bordeaux, Aquitaine, France
    Institut Bergonié
Jul 3, 2019

Genotyping of Ebus-tbna Supernant Cell-free Dna in Nsclc

Unknown status
  • Lung Cancer
  • Molecular analysis of surnatant
  • Toulouse, France
    Nicolas Guibert
Nov 9, 2020

Biliary Tract Tumors, Gastric Cancer, Esophageal Squamous Cell Carcinoma Trial in Beijing (FGFR Inhibitor, IDH1 Inhibitor, HER2

Unknown status
  • Biliary Tract Neoplasms
  • +8 more
  • FGFR Inhibitor, IDH1 Inhibitor, HER2 Inhibitor, PARP Inhibitor, BRAF Inhibitor, MEK Inhibitor, ICIs, EGFR-TKIs, NTRK-TKI, and et. al.
  • Other Therapy
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Oct 8, 2020

Genetic Predictors of Lithium Response in Bipolar Disorder

Completed
Has Results
  • Bipolar Disorder
  • Lithium treatment
  • San Diego, California
    VA San Diego Healthcare System, San Diego, CA
Jan 17, 2020

Chinese Non-Small Cell Lung Cancer Rare Driver Gene Mutation

Recruiting
  • Chinese
  • Non-Small Cell Lung Cancer
  • nonIntervention
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Dec 24, 2019

Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Feb 7, 2020

Obesity Trial in Paris La Defense

Recruiting
  • Obesity
    • Paris La Defense, France
      Pitié-Salpêtrière Hospital, AP-HP -Nutrition department
    Oct 21, 2020

    Low Grade Glioma Trial in Worldwide (Vinblastine, Bevacizumab)

    Recruiting
    • Low Grade Glioma
    • Los Angeles, California
    • +20 more
    Mar 11, 2020

    Non Small Cell Lung Cancer Trial in Italy (Cabozantinib 20 MG, Cabozantinib 40 MG, Cabozantinib 60 MG)

    Recruiting
    • Non Small Cell Lung Cancer
    • Cabozantinib 20 MG
    • +2 more
    • Bologna, Italy
    • +10 more
    Oct 17, 2019

    Recurrent Thyroid Gland Carcinoma, Stage I Thyroid Gland Papillary Carcinoma, Stage II Thyroid Gland Papillary Carcinoma Trial

    Completed
    Has Results
    • Recurrent Thyroid Gland Carcinoma
    • +4 more
    • Tampa, Florida
    • +5 more
    Dec 2, 2016

    Transient Receptor Potential Vanilloid One Receptor Expression

    Completed
    • Epigastric Pain
    • +3 more
      • Milwaukee, Wisconsin
        Medical College of Wisconsin
      Oct 21, 2015